Mirus Bio LLC Release: the First Dedicated Breast Cancer Cell Line Transfection Reagent
4/4/2013 9:22:47 AM
More...
|
Mirus Bio LLC Suit against Fugent Dismissed
1/17/2012 9:01:22 AM
More...
|
Mirus Bio LLC and Reinnervate Limited Collaborate to Introduce the 3D Transfection System: Enabling Transfection of Cells in 3D Culture
11/16/2011 11:04:10 AM
More...
|
Mirus Bio LLC to Award $250,000 of Transfection Products for Cutting Edge Research
7/12/2011 8:38:24 AM
More...
|
Mirus Bio LLC Release: Reagent Agent(SM) Transfection Cell Line Database from The Transfection Experts
3/8/2011 10:35:01 AM
More...
|
Mirus Bio LLC: Faster Biotherapeutic Protein Production With the New TransIT-PRO(TM) Transfection Kit
8/19/2010 8:27:01 AM
More...
|
Mirus Bio Corporation Releases for Sale TransIT(R)-2020
9/9/2009 8:37:00 AM
More...
|
Roche (RHHBY) (JOBS) Acquires Mirus Bio Corporation for $125 Million
7/22/2008 6:25:22 AM
More...
|
Mirus Bio Corporation Awarded Grants & Contracts of Over $5 Million
8/23/2007 11:44:05 AM
More...
|
Mirus Bio Corporation Awarded Grants & Contracts of Over $5 Million
8/23/2007 9:38:42 AM
More...
|
|